-->

Tag: NSCLC immunotherapy

Home / NSCLC immunotherapy

Categories

World-first lung cancer vaccine trials started in seven countries

August 2024: Medical professionals have initiated clinical trials for the first-ever mRNA lung cancer vaccine, which has been praised by specialists for its revolutionary ability to potentially rescue...
nsclc-immunotherapy

Neoadjuvant/adjuvant durvalumab is approved by the USFDA for resectable non-small cell lung cancer

August 2024: The Food and Drug Administration has granted approval for the use of durvalumab (Imfinzi, AstraZeneca) in combination with platinum-containing chemotherapy as a neoadjuvant treatment, fol...
nsclc-immunotherapy

Scan the code